To evaluate the efficacy and safety of the two most commonly used systemic treatments for PG. The study aims to test the hypothesis that systemic ciclosporin (4 mg/kg/day) is more effective than systemic prednisolone (0.75 mg/kg/day) for oral therapy of PG. Primary objective: To assess the speed of response to treatment - assessed by digital images at 6 weeks.